PERSISTENT EFFECTS OF (+/-)3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, ECSTASY) ON HUMAN SLEEP

被引:89
|
作者
ALLEN, RP
MCCANN, UD
RICAURTE, GA
机构
[1] NIMH, BIOL PSYCHIAT BRANCH, ANXIETY & AFFECT DISORDERS SECT, BLDG 10, BETHESDA, MD 20892 USA
[2] JOHNS HOPKINS UNIV, SCH MED, FRANCIS SCOTT KEY MED CTR, DEPT NEUROL, BALTIMORE, MD 21205 USA
来源
SLEEP | 1993年 / 16卷 / 06期
关键词
MDMA; SEROTONIN; NEUROTOXICITY; AMPHETAMINES; SLEEP;
D O I
10.1093/sleep/16.6.560
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
(+/-)3,4-methylenedioxymethamphetamine (MDMA) is a recreational drug of abuse which damages serotonin neurons in animals. It is not known whether MDMA is also neurotoxic in humans, and if so, whether there are functional consequences. Given the putative role of serotonin in sleep, it was hypothesized that one manifestation of serotonin neurotoxicity in humans might be disturbances of sleep. To determine whether MDMA use has effects on sleep, all-night polysomnograms of 23 MDMA users were compared to those of 22 age- and sex-matched controls. On average, MDMA users had 19 minutes less total sleep and 23.2 minutes less non-REM (NREM) sleep than controls. These statistically significant differences in NREM sleep were due primarily to an average of 37 minutes less stage 2 sleep, with no significant differences noted in stages 1, 3 or 4. Although it is not known whether the alterations in sleep observed in MDMA users are due to serotonin neurotoxicity, the present findings suggest that MDMA use can lead to persistent changes in CNS structures involved in human sleep generation.
引用
收藏
页码:560 / 564
页数:5
相关论文
共 50 条
  • [41] ACUTE EFFECTS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) ON MONOAMINES IN RAT CAUDATE
    GOUGH, B
    ALI, SF
    SLIKKER, W
    HOLSON, RR
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 39 (03) : 619 - 623
  • [42] Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, ''ecstasy'') and its congeners
    Huether, G
    Zhou, D
    Ruther, E
    JOURNAL OF NEURAL TRANSMISSION, 1997, 104 (8-9) : 771 - 794
  • [43] Post-Mortem (Re)Distribution of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): Human and Animal Data
    De Letter, Els A.
    Stove, Christophe P.
    Lambert, Willy E.
    Piette, Michel H. A.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2010, 11 (05) : 453 - 459
  • [44] Sub-acute effects of MDMA (±3,4-methylenedioxymethamphetamine, "ecstasy") on mood:: evidence of gender differences
    Verheyden, SL
    Hadfield, J
    Calin, T
    Curran, HV
    PSYCHOPHARMACOLOGY, 2002, 161 (01) : 23 - 31
  • [45] Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver
    Moon, Kwan-Hoon
    Upreti, Vijay V.
    Yu, Li-Rong
    Lee, Insong J.
    Ye, Xiaoying
    Eddington, Natalie D.
    Veenstra, Timothy D.
    Song, Byoung-Joon
    PROTEOMICS, 2008, 8 (18) : 3906 - 3918
  • [46] A comparison of the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") with cocaine in rhesus monkeys
    Lile, JA
    Ross, JT
    Lile, JA
    DRUG AND ALCOHOL DEPENDENCE, 2005, 78 (02) : 135 - 140
  • [47] Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans
    Harris, DS
    Baggott, M
    Mendelson, JH
    Mendelson, JE
    Jones, RT
    PSYCHOPHARMACOLOGY, 2002, 162 (04) : 396 - 405
  • [48] A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans
    Kirkpatrick, Matthew G.
    Gunderson, Erik W.
    Perez, Audrey Y.
    Haney, Margaret
    Foltin, Richard W.
    Hart, Carl L.
    PSYCHOPHARMACOLOGY, 2012, 219 (01) : 109 - 122
  • [49] A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans
    Matthew G. Kirkpatrick
    Erik W. Gunderson
    Audrey Y. Perez
    Margaret Haney
    Richard W. Foltin
    Carl L. Hart
    Psychopharmacology, 2012, 219 : 109 - 122
  • [50] Examining the role of oxytocin in the interoceptive effects of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') using a drug discrimination paradigm in the rat
    Broadbear, Jillian H.
    Tunstall, Brendan
    Beringer, Katherine
    ADDICTION BIOLOGY, 2011, 16 (02) : 202 - 214